Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
Tellus BioVentures
AddedFeb 15, 2024
UpdatedJul 16, 2026
Tellus BioVentures

Tellus BioVentures

Operating

Tellus BioVentures: A biotech investment fund accelerating early-stage life science innovation since 2019.

Location
Florida, NY, US
Founded
2019
Firm
Compare
Portfolio
Employees
Website

Tellus BioVentures is a biotechnology investment fund dedicated to early-stage innovation and company formation in the life sciences sector. Founded in 2019, the firm focuses on uncovering and accelerating promising biotech innovations, supporting talented entrepreneurs and scientists, and addressing unmet medical needs. Tellus BioVentures typically invests in seed and Series A rounds, with some involvement in Series B and other unspecified rounds.

Notable portfolio companies include Aegle Therapeutics, Interius BioTherapeutics, Navrogen, Praeventix, ViTToria Biotherapeutics, and Zenas BioPharma. The firm is led by key partners who bring extensive experience from various affiliations within the biotech industry. Tellus BioVentures emphasizes a hands-on investment philosophy, providing strategic guidance and operational support to help portfolio companies achieve their growth objectives.

Tellus BioVentures - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments8
Current Portfolio Count6
Total Portfolio Exits0

Top Investment Stages

Seed3 (37.5%)
Series Unknown3 (37.5%)
Series A2 (25.0%)

Stage Mix

Seed 38%Series Unknown 38%Series A 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

Cantai Therapeutics logo

Cantai Therapeutics

ViTToria Biotherapeutics logo

ViTToria Biotherapeutics

Praeventix logo

Praeventix

Navrogen logo

Navrogen

Interius BioTherapeutics logo

Interius BioTherapeutics

Aegle Therapeutics logo

Aegle Therapeutics

Tellus BioVentures - Classification

NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 6700Holding And Other Investment Offices
  • 6720Investment Offices
  • 6722Management Investment Offices, Open-end
Show 9 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 525000Funds, Trusts, and Other Financial Vehicles
  • 541000Professional, Scientific, and Technical Services
  • 523910Miscellaneous Intermediation
  • 523940Portfolio Management and Investment Advice
SIC
  • 6000Depository Institutions
  • 7300Business Services
  • 6790Miscellaneous Investing
  • 6799Investors, Not Elsewhere Classified